A brand-new class of aminoglycoside antibiotic with an elimination half-life of four hours is designed for intravenous administration. A clinical experiment compares two distinct dosage schedules: a lower dose administered three times per day and a greater dose administered once per day. In both regimens, the total daily dose per kilogram of body weight (mg/kg/day) is the same. The graph below shows the monitoring of serum medication levels in both groups: (extended interval) dosing, Green: multiple-daily dosing, MIC: minimum inhibitory concentration]
It is found that both regimens are effective against gram-negative pathogens, with clinical improvement occurring slightly earlier on average with once-daily dosing. Which of the following best explains the efficacy of once-daily dosing despite the short half-life of this antibiotic?
A) Concentration-dependent killing
B) High therapeutic index
C) Linear dose-response relationship
D) Low threshold dose
E) Time-dependent killing
Correct Answer:
Verified
Q227: When testing a novel drug's bioavailability, researchers
Q228: A 63-year-old man comes to the physician
Q229: Due to a rash, a 28-year-old male
Q230: A 45-year-old man with a history of
Q231: A 21-year-old man is brought to the
Q233: A 60-year-old woman with a seizure disorder
Q234: A 58-year-old man is brought to the
Q235: A 70-year-old man is brought to the
Q236: A 48-year-old man comes to the emergency
Q237: A 23-year-old man comes to the emergency
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents